Advice
Following a resubmission.
Sodium oxybate (Xyrem®) is not recommended for use within NHS Scotland for the treatment of cataplexy in adult patients with narcolepsy.
The manufacturer’s justification of the treatment’s cost in relation to its health benefits was not sufficient to gain acceptance by SMC.
Download detailed advice103KB (PDF)
Medicine details
- Medicine name:
- sodium oxybate 500mg/ml oral solution (Xyrem)
- SMC ID:
- 246/06
- Indication:
- for the treatment of cataplexy in adult patients with narcolepsy
- Pharmaceutical company
- UCB Pharma Ltd
- BNF chapter
- Central nervous system
- Submission type
- Resubmission
- Status
- Not recommended
- Date advice published
- 10 September 2007